Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479203 · ClinicalTrials.gov registry record · Early Phase 1
Acute Effects of E-Cigarette Aerosol Inhalation
A Early Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT03479203: Completed Early Phase 1 study, sponsored by University of Pennsylvania.
NCT03479203 is a Early Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03479203, a Early Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study comprises a portion of a larger study designed to compare results of vascular function in non-smokers to vascular function in healthy smokers chronically exposed to nicotinized electronic cigarette aerosol versus conventional cigarettes.
Interventions
- DRUG Electronic Cigarette Aerosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2022-08-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479203
The ClinicalTrials.gov registry entry for NCT03479203 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Cigarette Aerosol is the first listed.
NCT03479203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479203 about?
NCT03479203 is a clinical study titled "Acute Effects of E-Cigarette Aerosol Inhalation". This study comprises a portion of a larger study designed to compare results of vascular function in non-smokers to vascular function in healthy smokers chronically exposed to nicotinized electronic cigarette aerosol versus conventional cigarettes.
What is the current status of trial NCT03479203?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2018-05-22. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03479203?
The interventions under investigation include: Electronic Cigarette Aerosol (DRUG).
Who is sponsoring clinical trial NCT03479203?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.